Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ mice without influencing systemic atherosclerosis.

about

Glycosylated Chromogranin A: Potential Role in the Pathogenesis of Heart Failure.Holistic Regulation of Angiogenesis with Chinese Herbal Medicines as a New Option for Coronary Artery Disease

P2860

Q47702359-8DF6CA2E-08AC-4E48-92AE-60B40F585981 Q58784996-04A5CCB1-1AE9-435F-BED3-29A1712A3378

P2860

Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ mice without influencing systemic atherosclerosis.

Item

http://www.wikidata.org/entity/Q41672979

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Secretoneurin gene therapy imp ...... cing systemic atherosclerosis.

@en

type

Item

label

Secretoneurin gene therapy imp ...... cing systemic atherosclerosis.

@en

prefLabel

Secretoneurin gene therapy imp ...... cing systemic atherosclerosis.

@en

P1476

Secretoneurin gene therapy imp ...... cing systemic atherosclerosis.

@en

P2093

Daniela Lener

http://www.w3.org/2001/XMLSchema#string

Dominik Wolf

http://www.w3.org/2001/XMLSchema#string

Egon Demetz

http://www.w3.org/2001/XMLSchema#string

Ivan Tancevski

http://www.w3.org/2001/XMLSchema#string

Maria Wolf

http://www.w3.org/2001/XMLSchema#string

Markus Theurl

http://www.w3.org/2001/XMLSchema#string

Peter Marschang

http://www.w3.org/2001/XMLSchema#string

Reiner Fischer-Colbrie

http://www.w3.org/2001/XMLSchema#string

Rudolf Kirchmair

http://www.w3.org/2001/XMLSchema#string

Wilfried Schgoer

http://www.w3.org/2001/XMLSchema#string

P2860

The neuropeptide secretoneurin acts as a direct angiogenic cytokine in vitro and in vivo

Secretogranin II; a protein increased in the myocardium and circulation in heart failure with cardioprotective properties

The chromogranin-secretogranin family

Secretoneurin--a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C)

Reversal of experimental diabetic neuropathy by VEGF gene transfer

Vascular endothelial growth factor is a secreted angiogenic mitogen

Angiogenesis in cancer, vascular, rheumatoid and other disease

Mechanisms of angiogenesis and arteriogenesis

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease.

Oxidized low-density lipoprotein induces apoptosis in endothelial progenitor cells by inactivating the phosphoinositide 3-kinase/Akt pathway.

P304

96-106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CVR/CVU237

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P50

Piotr Tymoszuk

Karin Albrecht-Schgoer

P577

2014-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25377726

http://www.w3.org/2001/XMLSchema#string

P921

gene therapy

Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ mice without influencing systemic atherosclerosis.

about

P2860

P2860

Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ mice without influencing systemic atherosclerosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921